The University of Queensland Diamantina Institute aims to find solutions to diseases, and to find ways to better manage disease states. In order to take findings from the laboratory and bring them to the patient, researchers at the UQDI undertake clinical trials research. Clinical trials are research studies involving patients, which compare a new or different type of treatment with the best treatment currently available (if there is one). Some clinical trials look at possible ways to prevent illnesses, for example by testing new vaccines in healthy people. No matter how promising a new drug or treatment may appear during tests in a laboratory, it must go through clinical trials before its benefits and risks can really be known.

The following groups are currently looking for clinical trial participants:


The role of genetics in rheumatoid arthritis (RA) is well established; but why do some people develop the disease while their siblings or children remain healthy?

We are currently recruiting RA patients, their first degree relatives (children, parents and siblings), as well as healthy individuals without a RA family history, to shed light on this question.

You can help us better understand the intricate relation between the disease, genetics and other factors that may influence the onset of RA by taking part in our study. The research is led by the Gallipoli Medical Research Foundation in collaboration with the University of Queensland Diamantina Institute. The principal investigators are Dr Helen Benham and Prof Ranjeny Thomas, both clinical rheumatologists and translational medical researchers.

For more information, please contact

Clinical Trials section

Clinical Trial FAQs

he decision to participate in a clinical trial is an important and personal decision. The following frequently asked questions may assist in helping you make the decision.

Clinical Research Facilities